Weekly weight loss on Mounjaro: a realistic, week-by-week picture

Step 1: the first four weeks, adjustment before anything else

The starting dose of 2.5 mg exists to let your body settle into the medicine. Its job is tolerability, not fat loss. Most people notice little scale movement in weeks one and two, and that is expected. Your digestive system is adapting: gastric emptying slows, appetite signals begin to shift, and nausea or mild stomach discomfort is common as the body adjusts. Judging Mounjaro by week one's number on the scale is a bit like judging a long walk by the first five minutes.

The misconception worth letting go gently: some people expect to lose 2–3 kg in the first week, having read about dramatic early drops on social media. A genuine initial loss of 0.5–1.0 kg is a solid start. If the scale barely moves at week one, that is within normal range, it doesn't mean the medicine isn't working. Your prescriber is the right person to assess whether progress is on track.

Nausea, if it appears, usually settles within days to two weeks. Eating smaller portions, avoiding very fatty foods, and staying hydrated all help the first phase go more smoothly, and are worth discussing with your prescriber.

Step 2: weeks five to twelve, the medicine begins to do its main work

By the time most people move to 5 mg (around week five, subject to clinical review), appetite suppression becomes noticeably stronger. This is where weekly losses of 0.5–1.5 kg become realistic for many. The number varies with starting weight, how much of a calorie deficit the reduced appetite creates in practice, and physical activity.

It's worth reading about the range of weekly losses people actually report at each dose stage, because the clinical trial averages can be misleading: they include periods of plateau, dose-escalation lulls, and individual variation that smooths out across thousands of participants. Your week-by-week experience will look spikier than the graph.

Plateau weeks are common even when the medicine is working well. A week with no scale change while losing centimetres, or while muscle is maintained through exercise, is not a failure. Tracking measurements as well as weight gives a more complete picture, and the NHS Live Well healthy weight guidance has practical detail on realistic rate-of-loss expectations.

Step 3: higher doses and sustained loss across months

As titration continues through 7.5 mg, 10 mg, 12.5 mg and 15 mg, weekly losses often stabilise rather than accelerate. The body adapts; appetite suppression doesn't necessarily intensify with each dose increase in a straight line. What the higher doses tend to do is sustain the loss through the plateau periods that would otherwise stall lower doses.

Across the full 72-week SURMOUNT-1 programme, participants on 15 mg lost an average approaching 22.5% of body weight in some analyses. For a person starting at 100 kg, that is roughly 22 kg over a year and a half, or an average of about 0.6 kg per week, but with significant variation from week to week. For a fuller sense of how the overall Mounjaro results break down, the treatment results page covers the evidence in detail.

If you are thinking about how long before meaningful results appear, our page on how long Mounjaro takes to work goes into the timeline more specifically. And if the cost of a longer treatment course is on your mind, there is context on what private Mounjaro treatment involves in terms of process and transparency.

When weekly weight loss stalls, what the evidence actually says

Weeks with no movement are a routine part of treatment, not a sign something has gone wrong. The body periodically defends its current weight; this is a known physiological pattern, not a Mounjaro-specific quirk. If you have hit a run of several weeks with no change, it is worth reviewing what has shifted: sleep, stress, portion sizes drifting back up, activity levels. Our prescribers can review your progress and advise, that is exactly what the clinical support that comes with your treatment is for.

Specific no-loss weeks early in treatment are common enough to have their own questions: if week two or week three has produced nothing, the pages on week 2 with no weight loss and week 3 with no weight loss address those directly with clinical context. NICE guidance notes that if less than 5% of body weight has been lost after six months at the highest tolerated dose, continuing treatment should be reviewed, which is why ongoing clinical oversight matters throughout, not just at the start.

If you are at a point where a clinical conversation would help, our free consultation connects you with a GPhC-registered prescriber who can review your situation directly. That is more useful than a general guide like this one, which can only describe population-level patterns.